Free release
(R)-Anthracen-9-yl(3-(morpholine-4-carbonyl)-[1,4'-bipiperidin]-1'-yl)methanone hydrochloride

(R)-Anthracen-9-yl(3-(morpholine-4-carbonyl)-[1,4'-bipiperidin]-1'-yl)methanone hydrochloride

CAS No. :591778-70-0MDL No. :MFCD28167776Formula :C30H36ClN3O3Boiling Point :-Linear Structure Formula :-InChI Key :DUBN

Sales:Service@apichina.com
CAS No. :591778-70-0 Brand :Qitai
Formula :C30H36ClN3O3 M.W :522.08

Introduction

CAS No. :591778-70-0 MDL No. :MFCD28167776
Formula : C30H36ClN3O3 Boiling Point : -
Linear Structure Formula :- InChI Key :DUBNXJIOBFRASV-GJFSDDNBSA-N
M.W : 522.08 Pubchem ID :23589188
Synonyms :
CP-640186 hydrochloride
Chemical Name :(R)-Anthracen-9-yl(3-(morpholine-4-carbonyl)-[1,4'-bipiperidin]-1'-yl)methanone hydrochloride

Physicochemical Properties

Num. heavy atoms : 37
Num. arom. heavy atoms : 14
Fraction Csp3 : 0.47
Num. rotatable bonds : 5
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 161.29
TPSA : 53.09 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.04 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 4.85
Log Po/w (WLOGP) : 3.83
Log Po/w (MLOGP) : 3.12
Log Po/w (SILICOS-IT) : 3.94
Consensus Log Po/w : 3.15

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -6.08
Solubility : 0.000432 mg/ml ; 0.000000827 mol/l
Class : Poorly soluble
Log S (Ali) : -5.7
Solubility : 0.00104 mg/ml ; 0.000002 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -6.66
Solubility : 0.000115 mg/ml ; 0.00000022 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 4.14
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: